Skip to main content
. 2022 Mar 3;23(1):104–111. doi: 10.1080/15384047.2021.2011643

Figure 3.

Figure 3.

The role of ARID family subunits in the prognosis of immunotherapy in various cancer types. a: The prevalence of ARID family subunit mutations in various types of cancers; b-i: the role of ARID subunit mutations in the prognosis of immunotherapy in different types of cancers.